FDA to review "missing" drug company documents.
Lenzer
Jeanne
J
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects; D004282:Documentation; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D005473:Fluoxetine / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine